HIV-1C


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
07 12 2020
Historique:
received: 25 10 2020
revised: 26 11 2020
accepted: 26 11 2020
entrez: 10 12 2020
pubmed: 11 12 2020
medline: 25 2 2021
Statut: epublish

Résumé

HIV-1 compartmentalization in reservoir sites remains a barrier to complete HIV eradication. It is unclear whether there is variation in HIV-1

Identifiants

pubmed: 33297399
pii: v12121404
doi: 10.3390/v12121404
pmc: PMC7762280
pii:
doi:

Substances chimiques

RNA, Viral 0
env Gene Products, Human Immunodeficiency Virus 0
gag Gene Products, Human Immunodeficiency Virus 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Medical Research Council
ID : MC_PC_MR/P006922/1
Pays : United Kingdom
Organisme : Department of Health
ID : RP-2017-08-ST2-012
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 107752/Z/15/Z
Pays : United Kingdom

Références

J Virol. 2003 May;77(9):5540-6
pubmed: 12692259
J Virol. 2011 Sep;85(17):9167-75
pubmed: 21715484
Can J Infect Dis Med Microbiol. 2013 Winter;24(4):202-8
pubmed: 24489562
J Virol. 2003 Apr;77(7):4449-56
pubmed: 12634405
Nat Med. 2004 Mar;10(3):282-9
pubmed: 14770175
J Neurovirol. 2018 Aug;24(4):498-505
pubmed: 29691760
Virol J. 2015 May 14;12:74
pubmed: 25966986
J Clin Microbiol. 2011 Apr;49(4):1441-5
pubmed: 21367995
FEBS J. 2015 Dec;282(24):4679-91
pubmed: 26411545
Retrovirology. 2010 Mar 22;7:23
pubmed: 20307309
Brain. 2006 Jul;129(Pt 7):1872-83
pubmed: 16735456
Virol J. 2008 Jan 23;5:14
pubmed: 18215327
J Virol Antivir Res. 2015;4(1):
pubmed: 26167513
J Int AIDS Soc. 2009 Nov 11;12:33
pubmed: 19906308
Virology. 2007 Oct 10;367(1):222-34
pubmed: 17599380
Curr HIV Res. 2013 Jan;11(1):43-49
pubmed: 23305169
J Virol. 2007 Nov;81(22):12608-18
pubmed: 17728232
J Virol. 2010 Mar;84(5):2395-407
pubmed: 20015984
J Clin Virol. 2012 May;54(1):6-10
pubmed: 22336085
J Virus Erad. 2015 Apr;1(2):67-71
pubmed: 26430703
Hum Immunol. 2001 Feb;62(2):146-56
pubmed: 11182225
Clin Infect Dis. 2019 Sep 27;69(8):1345-1352
pubmed: 30561541
Evolution. 2007 Feb;61(2):272-9
pubmed: 17348938
Clin Infect Dis. 2019 Jan 18;68(3):393-401
pubmed: 29945252
ISRN AIDS. 2012 Dec 19;2012:823605
pubmed: 24052884
Virology. 2017 Jan 15;501:12-24
pubmed: 27846415
Proc Natl Acad Sci U S A. 2015 Jun 2;112(22):E2874-83
pubmed: 26038564
Glycobiology. 2004 Dec;14(12):1229-46
pubmed: 15175256
Nucleic Acids Res. 2014 Oct;42(18):e144
pubmed: 25120265
PLoS Pathog. 2015 Mar 26;11(3):e1004720
pubmed: 25811757
Virus Evol. 2016 Aug 03;2(2):vew020
pubmed: 27774305
AIDS Res Hum Retroviruses. 2018 Jul;34(7):607-620
pubmed: 29658309
AIDS Res Hum Retroviruses. 2009 Dec;25(12):1297-1305
pubmed: 20001314
PLoS Pathog. 2017 Jan 3;13(1):e1006112
pubmed: 28046096
J Acquir Immune Defic Syndr. 2010 Feb;53(2):167-75
pubmed: 19996764
Open Forum Infect Dis. 2017 Feb 12;4(2):ofx032
pubmed: 28470016
PLoS Pathog. 2011 Oct;7(10):e1002286
pubmed: 22007152
J Virol. 2010 Oct;84(20):10510-21
pubmed: 20686044
J Acquir Immune Defic Syndr. 2017 Jun 1;75(2):246-255
pubmed: 28328546
J Exp Med. 1991 Aug 1;174(2):407-15
pubmed: 1713252
Mem Inst Oswaldo Cruz. 2012 Jun;107(4):532-8
pubmed: 22666865
J Acquir Immune Defic Syndr. 2009 May 1;51(1):60-4
pubmed: 19390328
Syst Biol. 2010 May;59(3):307-21
pubmed: 20525638
J Virol. 2007 Mar;81(5):2359-71
pubmed: 17182681
AIDS. 2009 Jun 1;23(9):1047-57
pubmed: 19390419
J Virol. 1996 Sep;70(9):6288-95
pubmed: 8709256
Pediatr Infect Dis J. 2016 Jul;35(7):777-81
pubmed: 27078121
PLoS One. 2018 Feb 2;13(2):e0192060
pubmed: 29394269
Infect Genet Evol. 2013 Oct;19:337-48
pubmed: 23660484
J Acquir Immune Defic Syndr. 2011 May 1;57(1):46-50
pubmed: 21346588

Auteurs

Nametso Kelentse (N)

Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
School of Allied Health Professions, Faculty of Health Sciences, University of Botswana, Gaborone, Botswana.

Sikhulile Moyo (S)

Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.

Mompati L Mogwele (ML)

Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Department of Biological Sciences, University of Botswana, Gaborone, Botswana.

Doreen Ditshwanelo (D)

Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.

Baitshepi Mokaleng (B)

Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
School of Allied Health Professions, Faculty of Health Sciences, University of Botswana, Gaborone, Botswana.

Natasha O Moraka (NO)

Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Department of Pathology, Stellenbosch University, Stellenbosch 7505, South Africa.

Kwana Lechiile (K)

Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Botswana-University of Pennsylvania Partnership, Gaborone, Botswana.

Tshepo B Leeme (TB)

Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Botswana-University of Pennsylvania Partnership, Gaborone, Botswana.

David S Lawrence (DS)

Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Department of Clinical Research, Faculty of Infectious and Tropical Diseases, The London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.

Rosemary Musonda (R)

Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.

Ishmael Kasvosve (I)

School of Allied Health Professions, Faculty of Health Sciences, University of Botswana, Gaborone, Botswana.

Thomas S Harrison (TS)

Centre for Global Health, Institute for Infection and Immunity, St. George's University of London, London SW17 0RE, UK.

Joseph N Jarvis (JN)

Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Botswana-University of Pennsylvania Partnership, Gaborone, Botswana.
Department of Clinical Research, Faculty of Infectious and Tropical Diseases, The London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.
Department of Medicine, Division of Infectious Diseases, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

Simani Gaseitsiwe (S)

Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH